Oxygen Therapy & respiration Flashcards
Hypoxia
Lack of O2 in the tissues - leads to ischaemia and necrosis
Can be caused by Hypoxyaemia, poor blood flow, low Hb, haemoglobinopathies, impaired cellular useage (sepsis, cyanide poisoning)
Hypoxaemia
Low arterial Pa02
Can be due to: decreased inspired O2 (altitude), hypoventilation or type II resp failure, Shunts (ARDs), VQ mismatching (bronchospasm or PE) or diffusion defects (pulmonary fibrosis)
PaO2
The amount of O2 dissolved in the plasma - generally a small fraction of the total oxygen carried by the blood
Oxygen therapy is usually required when it falls to 60mmHg/8kPa (SaO2 around 90%)
SaO2
The Hb saturation with oxygen - produces a curve which moves depending on the physical and chemical states
Problematic below 90%
Oxygen dissociation curve
The curve of Hb oxygen saturation by amount of oxygen in the blood –> Moving it to the left increases oxygen binding while moving it to the right decreases oxygen binding
Factors which increase Hbs affinity for O2 (left shift) (5)
Hypothermia Alkalosis
Decreased PCO2 Decreased 2-3 DPG
Different forms of Hb (carboxy-, met-, foetal)
Factors which decrease Hbs affinity for O2 (right shift) (4)
Hyperthermia Acidosis Increased PCO2 (Bohr) Increased 2-3 DPG
Clinical assessment of oxygen transport (3)
Central or peripheral cyanosis (difficult if dark skin)
Increasing Resp Rate
Increased HR
Pulse oximetry
Measure SaO2 by the absorption spectra of the blood
Will be confused if they have nail polish on or if there is CO poisoning –> would need to send to a hyperbaric oxygen chamber
Arterial blood gases
This tells you the arterial PO2 and PCO2 and give a good picture –> make sure to correct for any oxygen therapy the patient is already on
Oxygen uptake
VO2
about 200-250mls/min
Oxygen delivery
DO2=(1.39xHb(g/dL)xSaO2/100) x cardiac output (ml/min)
Usually 1000mls/min
Indications for oxygen therapy (7)
Cardiorespiratory arrest or resp failure (PaO2<8) type I/II
MI or heart failure, shock, Post-operative, CO poisoning
Increased metabolic demand
Variable performance systems of oxygen therapy
No capacity systems –> nasal cannulae semi-rigid masks (MC, Hudson) - flow should be at least 4L/min to prevent rebreathing
Large capacity –> soft bag masks (pneumask, oxyaire)
Fixed performance systems of oxygen therapy
In these case the FiO2 is fixed - venture masks where % is controlled by the entrainment disc size (24,28,35,40%)
Low-flow breathing circuits with a reservoir to deliver a fixed FiO2
Hazards of Oxygen therapy
CO2 narcosis (COPD)--> loss of hypoxic drive, V/Q inequalities, Haldane effect Pulmonary and neurological Oxygen toxicity ICU (FiO2 >0.6). Retrolental fibroplasias in neonates
Indications for Mechanical ventilation (6)
To ensure high FiO2 and CO2 removal
To protect the airway of unconscious patients
Resp failure (type I or II), head injuries effecting CO2 elimination centres, heart failure causing a drop in CO,
Prophylactically in severe sepsis
CPAP
Continuous positive airway pressure
+5-12cmH20 pressure continuously
Reduce work of breathing and can open up atelectatic areas
PEEP
Positive end-expiratory pressure
+5-12cmH20 pressure at points during breathing Reduce work of breathing and can open up atelectatic areas
Oxygenation while under mechanical ventilation depends on four things
The FiP2 (fractional inspired oxygen)
Patent airways (mean airway pressure)
Blood suppy to the ventilated alveoli
Diffusion from the blood
Contraindications for non-invasive mechanical ventilation (5)
Severe hypoxia Low consciousness level Facial injuries or surgery Excessive secretions GI obstruction
Modes of mechanical ventilation
Spontaneous –> NIV,BiPAP, patient must be able to initiate breaths themselves
Controlled –> ventilator initiates breaths but can usually allow a degree of spontaneous breathing by the patient
FiO2
Fraction of inspired oxygen –> eg 28%
Depends on oxygen flow, device and patient factors (breathing rate and vital capacity)
CPAP
Continuous positive airway pressure - used for patients with sleep apnea, COPD/Type II respiratory failure or HF. Used in a spontaneously breathing patient. Can be used nasally or orally in infants. Can also be used where the patient is tiring to delay needing invasive ventilation.
Non-invasive ventilation
Mainly used for COPD in respiratory acidosis or any form of type II respiratory failure.
It can be used in Cardiogenic pulmonary oedema unresponsive to CPAP or to wean off tracheal intubation.
BPAP
A form of CPAP with changes in the applied pressure level depending on the stage in the breathing cycle.
PEEP
Positive end-expiratory pressure. Just used to apply pressure at the end of the breathing cycle.